RecruitingNCT04493385
The Hepatitis C Transplant Collaborative
Nationwide Hepatitis C NAT+ Cardiac Transplant Experience
Sponsor
Baylor Research Institute
Enrollment
500 participants
Start Date
Sep 16, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Recipient of a proven HCV NAT+ donor heart.
- Re-transplant patients will be included.
Exclusion Criteria1
- \. Multi-organ transplantation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04493385
Related Trials
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
NCT0689507014 locations
HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
NCT054519791 location
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT012808251 location
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
NCT0539042411 locations
Cardiopulmonary Stress Testing (CPET) AlloSure Study
NCT046560801 location